BioAffinity Technologies Inc

+0.01 (+0.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)9.92M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.1 Million
Adjusted EPS-$0.15
See more estimates
10-Day MA$1.25
50-Day MA$1.67
200-Day MA$1.82
See more pivots

BioAffinity Technologies Inc Stock, NASDAQ:BIAF

22211 West Interstate 10, Suite 1206, San Antonio, Texas 78257
United States of America
Phone: +1.210.698.5334
Number of Employees: 14


bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.